Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By stimulating these https://nikolasjsmw905888.dreamyblogs.com/36659709/retatrutide-a-promising-new-treatment-for-obesity